Table 10.
Summary of the TCGA dataset used in the study
| Tumor Type | Acronym | Tumor Tissue | Normal Tissue | Class |
|---|---|---|---|---|
| Adrenocortical carcinoma | ACC | 80 | 0 | 0 |
| Bladder Urothelial Carcinoma | BLCA | 411 | 19 | 1 |
| Breast invasivex carcinoma | BRCA | 777 | 87 | 2 |
| Cervical squamous cell carcinoma | CESC | 306 | 3 | 3 |
| Cholangiocarcinoma | CHOL | 36 | 9 | 4 |
| Lymphoid Neoplasm Diffuse Large B-cell Lymphoma | DLBC | 47 | 0 | 5 |
| Esophageal carcinoma | ESCA | 187 | 13 | 6 |
| Head and Neck squamous cell carcinoma | HNSC | 487 | 44 | 7 |
| Kidney Chromophobe | KICH | 66 | 25 | 8 |
| Kidney renal clear cell carcinoma | KIRC | 260 | 71 | 9 |
| Kidney renal papillary cell carcinoma | KIRP | 291 | 34 | 10 |
| Lower Grade Glioma | LGG | 528 | 0 | 11 |
| Liver hepatocellular carcinoma | LIHC | 374 | 50 | 12 |
| Lung adenocarcinoma | LUAD | 458 | 46 | 13 |
| Lung squamous cell carcinoma | LUSC | 341 | 45 | 14 |
| Mesothelioma | MESO | 86 | 0 | 15 |
| Pancreatic adenocarcinoma | PAAD | 154 | 4 | 16 |
| Pheochromocytoma and Paraganglioma | PCPG | 184 | 3 | 17 |
| Prostate adenocarcinoma | PRAD | 494 | 52 | 18 |
| Sarcoma | SARC | 260 | 0 | 19 |
| Skin Cutaneous Melanoma | SKCM | 450 | 2 | 20 |
| Stomach adenocarcinoma | STAD | 399 | 45 | 21 |
| Testicular Germ Cell Tumors | TGCT | 156 | 0 | 22 |
| Thyroid carcinoma | THCA | 513 | 59 | 23 |
| Thymoma | THYM | 124 | 2 | 24 |
| Uterine Corpus Endometrial Carcinoma | UCEC | 417 | 21 | 25 |
| Uterine Carcinosarcoma | UCS | 57 | 0 | 26 |
| Uveal Melanoma | UVM | 80 | 0 | 27 |
| Total | 8023 | 634 |